Krystal Biotech Inc (KRYS)
182.29
+4.19
(+2.35%)
USD |
NASDAQ |
Nov 21, 16:00
182.47
+0.18
(+0.10%)
After-Hours: 20:00
Krystal Biotech Debt to Equity Ratio: 0.00 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Sep 2023
--
Maximum
Sep 2023
--
Average
--
Median
Sep 2023
Debt to Equity Ratio Benchmarks
| Bioventus Inc | 2.579 |
| ADMA Biologics Inc | 0.437 |
| Alnylam Pharmaceuticals Inc | 31.64 |
| Amicus Therapeutics Inc | 2.178 |
| Rhythm Pharmaceuticals Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 982.32M |
| Total Liabilities (Quarterly) | 96.47M |
| Shareholders Equity (Quarterly) | 885.85M |
| Current Ratio | 7.966 |